Literature DB >> 24651138

Improving the management of tibia stress fractures: a collaborative, outpatient clinic-based quality improvement project.

Cindy L Roberts1, Christopher D Meyering, Michael E Zychowicz.   

Abstract

PURPOSE: Implement and evaluate the effectiveness of the Leg Pain Screening and Referral Tool (LPS&RT) for patients presenting with lower extremity leg pain in an outpatient clinic. SAMPLE: A total of 46 patients diagnosed with tibia stress fractures.
METHODS: The study employed a pre-/postintervention design. Retrospective and prospective information was collected from an electronic health record to obtain patient data. The pre- and postintervention groups were compared on the number of patients diagnosed with tibia stress fractures. Provider adherence to the treatments recommended by the algorithm was assessed by chart audits postintervention.
RESULTS: There was a significant increase (87.5%) in tibia stress fracture diagnosis, from 16 preintervention to 30 postintervention. Provider adherence to the LPS&RT was 93.3% postintervention. Common treatments were activity restriction, oral medication, and/or specialty referrals.
CONCLUSION: The LPS&RT was an effective, uniform measure to standardize the plan of care for tibia stress fractures in one outpatient clinic.

Entities:  

Mesh:

Year:  2014        PMID: 24651138     DOI: 10.1097/NOR.0000000000000032

Source DB:  PubMed          Journal:  Orthop Nurs        ISSN: 0744-6020            Impact factor:   0.913


  2 in total

1.  Evaluating an Algorithm and Clinical Prediction Rule for Diagnosis of Bone Stress Injuries.

Authors:  Nathaniel S Nye; Carlton J Covey; Mary Pawlak; Cara Olsen; Barry P Boden; Anthony I Beutler
Journal:  Sports Health       Date:  2020-08-07       Impact factor: 3.843

Review 2.  Improving Diagnostic Accuracy and Efficiency of Suspected Bone Stress Injuries.

Authors:  Nathaniel S Nye; Carlton J Covey; Lucas Sheldon; Bryant Webber; Mary Pawlak; Barry Boden; Anthony Beutler
Journal:  Sports Health       Date:  2016 May/Jun       Impact factor: 3.843

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.